BEIJING (AP) _ Sinovac Biotech Ltd. (SVA) on Wednesday reported fourth-quarter profit of $4.4 million.
On a per-share basis, the Beijing-based company said it had profit of 8 cents. Earnings, adjusted for stock option expense and non-recurring costs, were 11 cents per share.
The biopharmaceutical company posted revenue of $31.4 million in the period.
For the year, the company reported that its loss narrowed to $596,000, or 1 cent per share. Revenue was reported as $72.4 million.
Sinovac shares have risen 30 percent since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $7.67, a rise of 25 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SVA at https://www.zacks.com/ap/SVA